InflaRx N.V. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.47 | $157.41 M | -2.5 | 51 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $5.90 | $320.64 M | -1.97 | 145 | $20.76 M |
 DSGN
|
Design Therapeutics, Inc. | $5.32 | $217.51 M | -3.7 | 57 | $0 |
 ELDN
|
Eledon Pharmaceuticals, Inc. | $2.49 | $107.05 M | -2.26 | 20 | $0 |
 ERAS
|
Erasca, Inc. | $2.68 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.07 | $1.65 B | -11.47 | 97 | $0 |
 EYPT
|
EyePoint Pharmaceuticals, Inc. | $7.99 | $473.97 M | -5.03 | 121 | $46.02 M |
 FULC
|
Fulcrum Therapeutics, Inc. | $3.77 | $515.25 M | -5.15 | 76 | $2.81 M |
 GBIO
|
Generation Bio Co. | $2.40 | $216.88 M | -1.28 | 174 | $5.90 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.17 | $243.38 M | -1.59 | 129 | $0 |
 GRTX
|
Galera Therapeutics, Inc. | $0.08 | $5.93 M | -0.12 | 7 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $2.12 | $151.66 M | -3.17 | 45 | $19.94 M |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 18 | $9.16 M |
 INZY
|
Inozyme Pharma, Inc. | $5.18 | $286.39 M | -3.43 | 59 | $0 |
 KRON
|
Kronos Bio, Inc. | $0.98 | $44.62 M | -0.37 | 58 | $6.29 M |
 KZR
|
Kezar Life Sciences, Inc. | $0.54 | $49.85 M | -0.49 | 58 | $7.00 M |
 OCUP
|
Ocuphire Pharma, Inc. | $1.28 | $43.81 M | -3.6 | 14 | $19.05 M |
 PASG
|
Passage Bio, Inc. | $0.68 | $73.04 M | -0.77 | 58 | $0 |
 PLX
|
Protalix BioTherapeutics, Inc. | $1.06 | $82.11 M | 14 | 208 | $65.49 M |
 RVPH
|
Reviva Pharmaceuticals Holdings, Inc. | $1.35 | $42.94 M | -0.91 | 15 | $0 |
 SLS
|
SELLAS Life Sciences Group, Inc. | $1.26 | $83.74 M | -1.34 | 16 | $0 |
 STOK
|
Stoke Therapeutics, Inc. | $12.23 | $774.50 M | -6.14 | 110 | $8.78 M |